-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In the United States, stroke is still one of the leading causes of disability and death.
Stroke
Recently, the medsci.
medsci.
The researchers analyzed samples of hospitalized patients nationwide from 2006 to 2015 and used the validated International Classification of Diseases Ninth Revision (ICD-9) code to determine adult ischemia with or without thrombolytic therapy and CCIs Patients with sexual stroke.
Among 4249201 patients with ischemic stroke, 3.
In the fully adjusted model, thrombolytic therapy and intravascular thrombectomy increased the likelihood of receiving CCIs by 6% and 10%, respectively.
It can be seen that regardless of the type of acute treatment, patients with ischemic stroke receiving CCI have increased.
Regardless of the type of acute treatment, patients with ischemic stroke receiving CCI have increased.
Original source:
Kristie M.
Decade‐Long Nationwide Trends and Disparities in Use of Comfort Care Interventions for Patients With Ischemic Stroke.
Leave a message here